about
Influence of diabetes mellitus on heart failure risk and outcomeA common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trialTransendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiencyMeasuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice.Registry of transcatheter aortic-valve implantation in high-risk patients.Angioplasty in the diabetic patient.Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction.Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategies.Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies.Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation.Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize ResultAtherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration.Meta-Analysis of Abdominal Aortic Aneurysm in Patients With Coronary Artery Disease.Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.The presence of apoptotic bone marrow cells impairs the efficacy of cardiac cell therapy.Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT).Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(®) devices: Results from the FRANCE 2 Registry.Does optical coherence tomography optimize results of stenting? Rationale and study design.Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome.Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques.Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry.A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry.Free leptin, carotid plaque phenotype and relevance to related symptomatology: insights from the OPAL-Lille carotid endarterectomy study.Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits.Alterations in neutrophil production and function at an early stage in the high-fructose rat model of metabolic syndrome.The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves.The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up.Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study.
P50
Q24800363-A92D8118-9B6A-41E7-B510-5571CE47499CQ24817217-EBFBC199-3F0A-42B6-ACD5-8F9697251A90Q33745962-1A1D18BA-E038-4DF3-AC60-84BBB85FA8D6Q33762062-FDE4B683-8DCE-4C86-ADC6-AF2AC6320E25Q33985997-D4AC8B4D-D5C3-4CE3-BA78-333F6C63C6BDQ34044204-BB0D5E26-BD9A-488E-89FA-578887764805Q34178870-76D76E9D-3889-45C2-B993-9F850BDBBDD7Q34450432-B7FEEE29-3014-4904-8B18-5B8B784E9E86Q34637935-6A633E09-F88E-401B-8AB1-D120320F25DFQ35618042-A12AFFFA-FFD9-4FF5-8427-5D00952D2815Q35781216-01F15532-6D39-4E56-8B12-50453138D78AQ36327657-C0B8846C-E726-465F-BE53-E308FCB83986Q37767614-80D907CB-DEC1-4464-A71D-A9F91D5374E5Q38095795-14E59511-317A-4491-A116-9D77221ED2B5Q38380904-02EF8385-DD33-4DD6-9831-1CE77B858037Q38388256-BBCF58C1-BA0D-44C2-A447-D2E44117A08EQ38550279-8B7A98D1-C0B4-41D6-AF1D-B762F8C5F230Q38582566-FFF31621-8605-4B2F-B0C2-92F597FCFB7DQ39199676-29896869-7E23-4DE9-A18A-F30BFBAAF21BQ39629646-5E47610C-DDF3-4EBC-83F2-35FC332E8FD9Q40285858-3D053157-58CC-4608-A520-6D021E526F31Q40583948-CBA517BA-6CED-4A93-AFCE-DD41BEE061F9Q41205746-E8F07CBB-3934-409B-8910-49A23A53EEFAQ41602235-AF521A63-DB6A-4B85-8F8E-800A22B64C77Q42674156-0CE732BE-E077-4F19-B7AA-2E7EBCB8FC75Q43673479-3D9B06FE-5FA9-49C1-B904-0E79645802D8Q43701438-4BF0D746-F389-4EC2-B162-7B69F169FBA2Q44460659-1F210C40-389B-40EE-8568-FE308D860A06Q44604255-6363168E-846D-43B6-AC60-4F2BCFBADD8BQ44844669-7ED9C863-5A4C-46DD-9265-1BC17B5EEE85Q45769229-5FA1C92C-69AE-4B96-94E1-F66DE6927908Q45787291-D079236A-4E04-426D-825B-15E20BF28A41Q46627058-C0D45E9A-0D6A-47A8-B7C0-707B5607A1DBQ46855188-7E25792A-10EC-44DD-8639-5557CA5DE96BQ47281598-58F5A675-BFD8-4991-A9FB-E42D03DF628CQ47674466-6FB89ED7-9DFA-4D4F-85CA-D643B867E353Q47685113-785C85C8-1166-454A-BDE1-FBC2CFB1DE47Q47730867-6CEB7223-EBE0-458B-BB3F-5682614D3E74Q48151897-9495E962-BDC0-473B-A207-A12768726010Q48249983-4DDFD107-F3B5-4BCA-BFCC-F6C50855A844
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Van Belle
@ast
Eric Van Belle
@en
Eric Van Belle
@es
Eric Van Belle
@nl
type
label
Eric Van Belle
@ast
Eric Van Belle
@en
Eric Van Belle
@es
Eric Van Belle
@nl
prefLabel
Eric Van Belle
@ast
Eric Van Belle
@en
Eric Van Belle
@es
Eric Van Belle
@nl
P106
P31
P496
0000-0001-6509-443X